Navigation Links
Pharmacyclics Announces Data Presentations for Ibrutinib in B-Cell Malignancies
Date:12/10/2013

ts' first treatment at OSU (OSU Tx1), 16% (n=27), 33% (n=58), and 51% (n=89) of pts received an ibrutinib-based therapy, cyclin-dependent kinase inhibitor-based therapy (CDKi), or other therapies (O), respectively.

The ORR was significantly different among groups at 56%, 45%, and 24% in the ibrutinib, CDKi, and O groups, respectively. 12-month progression free survival (PFS) estimates were 77%, 38%, and 17% in the ibrutinib, CDKi, and O groups, respectively. 12-month overall survival (OS) estimates were 81%, 78%, and 58%. Notably, age did not correlate with response, PFS, or OS.

-ORAL PRESENTATION- CLL Abstract #673:
Single Agent Ibrutinib Achieves Equal Responses in CLL Patients With and Without Deletion 17p
Mohammed Farooqui, DO, National Institutes of Health, National Heart, Lung and Blood Institute, Bethesda, MD

This phase 2, single center, study of ibrutinib as a single-agent aimed to address the role of ibrutinib in the treatment of CLL patients with del 17p, regardless of their prior treatment history. The study enrolled 29 patients with del 17p, and 24 elderly patients without del 17p (NL 17p). Fifteen of the del 17p patients and eight of the NL 17p patients were treatment naive. The primary endpoint of the study was response after 6 months, assessed by computed tomography (CT) scans, bone marrow biopsies, and routine clinical and laboratory studies.

At six months, 47 patients were evaluable. Of the patients with del 17p, 53% achieved a PR and 43% achieved a PRL, compared to 82% PR and 9% PRL among the NL 17p patients. The apparent difference in response rates is due to slower clearance of the treatment-induced lymphocytosis in the del 17p patients; however, the clinical benefit and disease control in all tissue sites was equal for both cohorts of patients. Twenty-month PFS was 100% in the NL 17p cohort, and 85% in the del 17p cohort.

The
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. WuXi PharmaTech to Partner with Pharmacyclics
2. Pharmacyclics Reports Third Quarter 2013 Results
3. Pharmacyclics Announces Date of Conference call to discuss Financial Results for Third Quarter Ended September 30, 2013
4. Pharmacyclics Reports Second Quarter 2013 Results
5. Pharmacyclics Announces Date of Financial Results for Second Quarter Ended June 30, 2013 and Conference Call
6. Pharmacyclics Reports First Quarter 2013 Results
7. Pharmacyclics Announces Date of Financial Results for Three Months Ended March 31, 2013 and Conference Call
8. Pharmacyclics Triggers Fourth Milestone Payment for Enrollment of 5th Patient in Frontline Phase III CLL Study
9. Pharmacyclics Announces Third Breakthrough Therapy Designation for Ibrutinib from the U.S. Food and Drug Administration
10. Pharmacyclics, Inc. Prices Public Offering of Common Stock
11. Pharmacyclics, Inc. Announces Proposed Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... Sept. 19, 2014 The Parenteral Drug Association ... global post-approval changes protocols. The new ... topic expressed by industry participants and regulatory authority representatives ... month in Washington, DC . Representatives ... hand for the workshop. Attendees indicated openness to engaging ...
(Date:9/19/2014)... 2014 Today, iHealth Lab Inc. announced it has ... for its first institutional round of funding. The strategic ... reach, accelerate growth and innovation, and invest in additional ... Xiaomi Ventures will join iHealth,s board of directors, bringing ... ecommerce. "We are very pleased to have ...
(Date:9/19/2014)... , September 19, 2014 ... ) has announced the addition of the ... report to their offering.      ... have been broadly classified into wide categories ... used for the treatment of different gynecological ...
Breaking Medicine Technology:PDA Launches Effort to Harmonize Global Post-Approval Changes Protocols 2iHealth Raises $25 Million to Fuel Growth and Global Market Share 2Global Gynecological Devices Market 2014-2018: Key Vendors are Bayer, Boston Scientific, CooperSurgical, Ethicon, Hologic, Medtronic, Olympus and Stryker 2Global Gynecological Devices Market 2014-2018: Key Vendors are Bayer, Boston Scientific, CooperSurgical, Ethicon, Hologic, Medtronic, Olympus and Stryker 3
... in ... developing countries, SEATTLE, Jan. 22 ... has joined the Global Health,Program as director of Global Health Delivery. ... medical and public health,efforts, including preparations for a potential influenza pandemic., ...
... Diagnostic Application of Research Technologies, FULLERTON, Calif., ... ) announced today that it has signed four ... to direct assay,research and acquire licenses for intellectual ... for the company,s future molecular,diagnostic instrument. Under the ...
Cached Medicine Technology:Dr. Rajeev Venkayya Joins Gates Foundation as Director of Global Health Delivery 2Beckman Coulter Announces Licensing Agreements for Molecular Tests with National University of Ireland, Galway 2Beckman Coulter Announces Licensing Agreements for Molecular Tests with National University of Ireland, Galway 3
(Date:9/21/2014)... An experienced review website in the global market, ... and announced that FatCow ( http://www.top10bestseohosting.com/go/FatCow.com/ ), GoDaddy and ... There has been a boom in websites in recent ... increase in the number of web hosting companies that ... prices. VPS (Virtual Private Server) is the method of ...
(Date:9/21/2014)... (PRWEB) September 21, 2014 Developers and ... have announced a new transition plugin entitled Transpack ... 3 delivers high quality transitions that will add a ... Christina Austin, CEO of Pixel Film Studios. “Blurring the ... a definite game changer.” , Transpack Vol. 3 returns ...
(Date:9/21/2014)... 2014 According to latest National Vital ... rate since 1966 (10.5 births per 1,000 women in 2013). ... has risen steadily by 2 percent per year. The birth ... aged 50 and over) also rose, the first such increase ... than nine times as many first births to women aged ...
(Date:9/20/2014)... UWDress.com, a professional company of women’s dresses and related ... evening cocktail dresses . As a matter of ... very popular among worldwide customers. Now, all its evening ... 65 percent off). , All UWDress.com’s employees are ... for the global clients. The company is famous for ...
(Date:9/20/2014)... 6 Minutes to Skinny , a ... Ballantyne that is showing men and women of all ages ... body fat using simple 6-minute exercises and easy-to-follow lifestyle tips ... investigative review. , “When it comes to losing body ... out for all people,” reports Michaels. “Metabolism plays a big ...
Breaking Medicine News(10 mins):Health News:Top10BestSEOHosting.com: FatCow, GoDaddy And Bluehost Are The Best VPS Hosting Suppliers 2Health News:Pixel Film Studios Released Transpack Vol. 3 Plugin Exclusively for Final Cut Pro X 2Health News:Statistics Reveal That the Number of 'Older' First-Time Mothers Is Growing 2Health News:Statistics Reveal That the Number of 'Older' First-Time Mothers Is Growing 3Health News:Statistics Reveal That the Number of 'Older' First-Time Mothers Is Growing 4Health News:Cheap Evening Cocktail Dresses Recently Introduced At UWDress.com 2Health News:6 Minutes to Skinny: Review Exposes Craig Ballantyne’s Method to Jump Starting the Metabolism and Blasting Away Body Fat in Just 6 Minutes Per Day 2
... showing signs of changes that could lead to full-blown ... today's "baked potato generation"// could be falling prey to ... ,It has been recognised for some time that being ... of diabetes, but authentication is growing that younger patients ...
... take as much care of your hair as you do of ... that the outer layer of the hair - the cuticle - ... dry and faded.// Hair damage occurs from a range of causes ... exposure. Ideally, you'd pay as much attention to your hair as ...
... specific toxin can cause a severe, highly lethal type ... They have so far linked infection with these toxin-carrying ... tissue destruction in the respiratory tract. ,According ... of the National Reference Center for Staphylococcal Toxemia in ...
... treat both major strains of influenza in young children said ... flu season because production problems delayed its distribution. The medication, ... season. Hoffmann-La Roche informed the FDA of its production problems, ... required to do so. // ,Tamiflu is one of ...
... be suffering from anxiety or depression. According to a ... before aggressive treatments are begun// for gastrointestinal disorders. This ... harmful medications for nausea, unnecessary medical investigation and probably ... ,Haug and colleagues in the department of psychiatry conducted ...
... folic acid intake and decreasing alcohol help beat the risk ... to previous studies have shown that colon cancer often runs ... the disease, you can opt for regular colon exams, cut ... vegetables to reduce your cancer risk. ,According to ...
Cached Medicine News:Health News:Toxin connected to 'Flesh-eating' Pneumonia in Kids 2
... The pause of a heartbeat. The ... of rhythmic breathing. These vital signs are ... check. DeRoyals line of Temperature Monitoring products ... the information needed to provide the most ...
... pause of a heartbeat. The bodys warmth ... breathing. These vital signs are yours to ... line of Temperature Monitoring products helps you ... needed to provide the most comfortable and ...
... is a portable, compact, lightweight system with ... emitting the same intensity (50 mW/cm) of ... smaller treatment area (30 cm). Excilite- possesses ... satisfy the most demanding professional users. The ...
... Smart 1064 is a laser system with ... versions with maximum continuous intensities of either 60 ... valid ally in all-mini-invasive surgical techniques. This laser ... it is the most requested from hospitals and ...
Medicine Products: